New FTC Report: PBMs Mark Up Specialty Generic Drugs
Pharmacy benefit managers’ (PBMs) charge significant mark ups for cancer, HIV and other specialty generic drugs, according to a new interim report from the Federal Trade Commission (FTC) published today. This latest report indicates that the three largest …